Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland
· Delayed Price · Currency is CHF 96.10
-11.30 (-10.52%)
At close: Mar 9, 2026
Cosmo Pharmaceuticals Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,532 | 1,677 | 1,022 | 818 | 1,003 | 1,105 | Upgrade
|
| Market Cap Growth | 43.55% | 64.05% | 24.91% | -18.39% | -9.22% | -10.15% | Upgrade
|
| Enterprise Value | 1,490 | 1,567 | 902 | 780 | 962 | 1,066 | Upgrade
|
| Last Close Price | 96.10 | 105.20 | 61.49 | 47.80 | 56.28 | 59.21 | Upgrade
|
| PE Ratio | - | - | 8.18 | - | 58.91 | 49.16 | Upgrade
|
| Forward PE | 49.56 | - | 7.78 | 28.23 | 35.51 | 63.09 | Upgrade
|
| PS Ratio | 15.79 | 17.29 | 4.08 | 9.48 | 9.94 | 16.37 | Upgrade
|
| PB Ratio | 3.36 | 3.68 | 2.16 | 2.18 | 2.19 | 2.08 | Upgrade
|
| P/TBV Ratio | 12.42 | 13.60 | 3.48 | 3.43 | 14.09 | 9.52 | Upgrade
|
| P/FCF Ratio | - | - | 6.90 | 45.41 | 35.34 | 149.55 | Upgrade
|
| P/OCF Ratio | - | - | 6.71 | 38.72 | 30.54 | 84.48 | Upgrade
|
| EV/Sales Ratio | 15.36 | 16.16 | 3.60 | 9.03 | 9.54 | 15.80 | Upgrade
|
| EV/EBITDA Ratio | 168.12 | 176.83 | 5.99 | 90.38 | 23.65 | 57.74 | Upgrade
|
| EV/EBIT Ratio | - | - | 6.46 | - | 34.71 | 92.64 | Upgrade
|
| EV/FCF Ratio | -95.90 | - | 6.09 | 43.26 | 33.92 | 144.35 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.37 | 0.33 | Upgrade
|
| Debt / EBITDA Ratio | 0.45 | 0.45 | 0.01 | 0.18 | 4.14 | 9.20 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.01 | 0.10 | 6.05 | 23.85 | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | -0.10 | -0.28 | -0.12 | -0.14 | -0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.42 | -5.42 | -0.88 | -5.23 | -1.64 | -2.94 | Upgrade
|
| Net Debt / FCF Ratio | 3.09 | 3.09 | -0.89 | -2.50 | -2.35 | -7.34 | Upgrade
|
| Asset Turnover | 0.17 | 0.17 | 0.46 | 0.14 | 0.13 | 0.09 | Upgrade
|
| Inventory Turnover | 4.48 | 4.48 | 3.27 | 3.06 | 3.29 | 3.50 | Upgrade
|
| Quick Ratio | 4.15 | 4.15 | 3.39 | 3.22 | 1.45 | 11.77 | Upgrade
|
| Current Ratio | 7.18 | 7.18 | 4.19 | 4.07 | 1.57 | 12.99 | Upgrade
|
| Return on Equity (ROE) | -0.70% | -0.70% | 29.31% | -2.47% | 3.58% | 4.75% | Upgrade
|
| Return on Assets (ROA) | -0.32% | -0.32% | 15.87% | -0.18% | 2.24% | 0.99% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.74% | -0.81% | 35.94% | -0.50% | 4.68% | 2.46% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.60% | -0.60% | 24.90% | -0.40% | 5.00% | 1.40% | Upgrade
|
| Earnings Yield | -0.22% | -0.20% | 12.23% | -1.23% | 1.70% | 2.03% | Upgrade
|
| FCF Yield | -1.01% | -0.93% | 14.49% | 2.20% | 2.83% | 0.67% | Upgrade
|
| Dividend Yield | 1.72% | - | 3.13% | 3.90% | 1.84% | 1.66% | Upgrade
|
| Payout Ratio | - | - | 24.09% | - | 90.61% | - | Upgrade
|
| Buyback Yield / Dilution | 2.76% | 2.76% | -1.94% | 1.95% | 2.83% | -16.81% | Upgrade
|
| Total Shareholder Return | 4.49% | 2.76% | 1.19% | 5.85% | 4.68% | -15.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.